SG/CALL/IPSEN/130/0.05/21.06.24 | Market Closed - Euronext Paris 10:00:00 31/05/2024 pm IST | ||
| 0.025 EUR | -.--% |
|
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
| Date | Price | Change |
|---|---|---|
| 31/24/31 | 0.025 | -.--% |
| 30/24/30 | 0.025 | -.--% |
| 29/24/29 | 0.025 | -.--% |
| 28/24/28 | 0.025 | -28.57% |
| 27/24/27 | 0.035 | -36.36% |
Real-time Euronext Paris
Last update May 31, 2024 at 10:00 pm IST
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | IPSEN |
| Issuer | 
Société Générale
|
| 18M2S | |
| ISIN | DE000SW9XKJ4 |
| Date issued | 03/05/2024 |
| Strike | 130 € |
| Maturity | 21/06/2024 (20 Days) |
| Parity | 20 : 1 |
| Emission price | 0.06 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.085 € |
|---|---|
| Lowest since issue | 0.015 € |
| Spread | 0.01 € |
| Spread % | 33.33% |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
120.6
EUR
Average target price
126.4
EUR
Spread / Average Target
+4.81%
- Stock Market
- Warrants
- 18M2S Warrant
